MedRegulus
ActiveSummary
The computed 12-month bankruptcy probability of MedRegulus is 1.6% (moderate). The 2025 annual accounts show negative equity (-€256,512) and a net result of -€9,117. Equity is shrinking by about 48% per year across the filed financial years. Its solvency ranks better than 5% of 1,130 sector peers (NACE 77, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-09
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 61 days late
2025
30-08
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 30 days late
2024
31-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 31 days late
2023
31-12
Financial
Weakest financial yearnet -€207,015
Net result drops to -€207,015, the lowest in the series; recovery starts the following year.
12-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Highest result from 2021 to 2025net €27,576 ▲194%
Operating result €242,703, net result €27,576, both a record.
22-07
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.